VBI Vaccines Inc (VBIV.OQ)
13 Jul 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|2015||Chairman of the Board|
|56||2015||Chief Executive Officer, Director|
|52||2017||Principal Financial and Accounting Officer, Senior Vice President - Finance, Chief Compliance Officer, Corporate Controller|
- BRIEF-VBI Vaccines Announces Positive Final Phase 1 Study Results Of Preventative CMV Vaccine
- BRIEF- Vaccines Posts Q1 Loss Per Share $0.19
- BRIEF-VBI Vaccines Announces Completion Of Enrollment In Protect Phase 3 Clinical Study For Sci-B-Vac Hepatitis B Vaccine
- BRIEF-VBI Vaccines Posts Positive DSMB Review Of Recurrent Glioblastoma Study
- BRIEF-Vbi Vaccines Announces Voluntary Delisting From The Toronto Stock Exchange